# A Study With GW597599 And GR205171: Potential New Drugs For The Treatment Of Primary Insomnia

> **NCT00606697** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 51 (actual)

## Conditions studied

- Sleep Initiation and Maintenance Disorders

## Interventions

- **DRUG:** GR205171
- **DRUG:** GW597599

## Key facts

- **NCT ID:** NCT00606697
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12-19
- **Primary completion:** 2008-05-07
- **Final completion:** 2008-05-07
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2017-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00606697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00606697, "A Study With GW597599 And GR205171: Potential New Drugs For The Treatment Of Primary Insomnia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00606697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*